Fischer Medical Ventures Reports Rs 2,607.75 Lakh Standalone Profit Before Tax for Quarter Ended September 30, 2026
Company posts total standalone income of Rs 3,065.34 lakh and consolidated profit before tax of Rs 875.26 lakh in the quarter
Fischer Medical Ventures Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Key highlights include total income reaching Rs 3,065.34 lakh standalone for the quarter, profit before tax of Rs 2,607.75 lakh standalone, and consolidated total income of Rs 11,201.82 lakh with profit before tax of Rs 875.26 lakh for the same period. The results include limited review reports by M/s. Bilimoria Mehta & Co.
Fischer Medical Ventures Limited
Financial Results
Fischer Medical Ventures Limited has released its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, showing significant income and profit before tax figures for the reporting periods.
The standalone financial results for the quarter ended September 30, 2026, show total income of Rs 3,065.34 lakh and profit before tax of Rs 2,607.75 lakh.
For the half year ended September 30, 2026, standalone total income was Rs 3,226.57 lakh with profit before tax of Rs 2,284.77 lakh.
Consolidated results for the quarter ended September 30, 2026, recorded total income of Rs 11,201.82 lakh and profit before tax of Rs 875.26 lakh.
In the half year period, consolidated total income was Rs 19,542.24 lakh and profit before tax was Rs 1,658.48 lakh.
The results have been approved by the Board of Directors and accompanied by limited review reports from the company's chartered accountants, M/s. Bilimoria Mehta & Co.
Highlights
- Standalone total income of Rs 3,065.34 lakh for quarter ended September 30, 2026.
- Standalone profit before tax of Rs 2,607.75 lakh for the same quarter.
- Consolidated total income of Rs 11,201.82 lakh and profit before tax of Rs 875.26 lakh in the quarter.
- Half-year standalone profit before tax stood at Rs 2,284.77 lakh.
- Board meeting for approval held on November 14, 2026, from 6:00 PM to 10:10 PM IST.
Key Data Snapshot
What happened
- Fischer Medical Ventures Limited announced unaudited standalone and consolidated financial results for quarter and half-year ended September 30, 2026.
- The Board of Directors approved the results on November 14, 2026, in a meeting lasting from 6:00 PM to 10:10 PM IST.
- Limited review reports by M/s. Bilimoria Mehta & Co., Chartered Accountants were received and included in the filing.
Key details
- Standalone total income stood at Rs 3,065.34 lakh for the quarter and Rs 3,226.57 lakh for the half year ended September 30, 2026.
- Standalone profit before tax was Rs 2,607.75 lakh for the quarter and Rs 2,284.77 lakh for the half year.
- Consolidated total income was Rs 11,201.82 lakh for the quarter and Rs 19,542.24 lakh for the half year.
- Consolidated profit before tax reached Rs 875.26 lakh for the quarter and Rs 1,658.48 lakh for the half year.
- Financial statements conform with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 format.
Regulatory and governance context
- The results were prepared and published as per SEBI Listing Regulations.
- An extract of the results will be published in English and Telugu newspapers.
- The company also uploaded the results to its website www.fischermv.com for investor access.
Highlights
- Standalone total income of Rs 3,065.34 lakh for quarter ended September 30, 2026.
- Standalone profit before tax of Rs 2,607.75 lakh for the same quarter.
- Consolidated total income of Rs 11,201.82 lakh and profit before tax of Rs 875.26 lakh in the quarter.
- Half-year standalone profit before tax stood at Rs 2,284.77 lakh.
- Board meeting for approval held on November 14, 2026, from 6:00 PM to 10:10 PM IST.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Balaji Telefilms Announces Unaudited Q2 and H1 Financial Results for September 30, 2026
Balaji Telefilms Limited has released its unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2026. The results were reviewed by the company's independent auditor Deloitte Haskins & Sells LLP and include financial data from its subsidiaries Balaji Motion Pictures Limited and Ding Infinity Private Limited.
Read Full StoryGenesys International Announces Q2 FY2027 Unaudited Financials and Grants 3.65 Lakh Employee Stock Options at Discounted Prices
Genesys International Corporation Limited disclosed its unaudited standalone and consolidated financial results for Q2 and H1 ended September 30, 2026, reporting a profit before tax of Rs.727.84 lakh in the quarter. The company also approved the grant of 3,65,000 employee stock options under its 2022 ESOP scheme, with exercise prices between Rs.70 to Rs.100, discounted significantly from the previous day's NSE closing price.
Read Full StoryShri Ram Apartment Development Co Ltd Submits Incomplete Filing with No Financial or Corporate Data
Shri Ram Apartment Development Co Ltd submitted a filing to BSE that only references annexures but does not contain any financial, corporate, or transactional information.
Read Full Story